NDA 207989 describes MOMETASONE FUROATE, which is a drug marketed by
Anda Repository,
Cosette,
Fougera Pharms,
Glenmark Pharms Inc,
Taro,
Encube,
Glenmark Pharms Ltd,
Padagis Israel,
Padagis Us,
Torrent,
Amneal,
Amneal Pharms,
Apotex, and
Aurobindo Pharma, and is included in twenty-two NDAs. It is available from
fifteen suppliers. Additional details are available on the
MOMETASONE FUROATE profile page.
The generic ingredient in MOMETASONE FUROATE is
mometasone furoate. There are thirty
drug master file entries for this compound. Twenty-four
suppliers are listed for this compound. Additional details are available on the
mometasone furoate profile page.